GB Meka
Stocks to watch

PGNY

Compare

Progyny Inc · Healthcare

$25.22
▲ 1.7%Close 2026-09-30

Live intraday price

Compare with our price levels

T227.58
T126.51
E123.75
E320.02
SL19.32

Close 2026-09-30: $25.22 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 5.8% · 1 whale recently bought

1 month
▼ 1.4%
3 months
▼ 14.4%
1 year
▲ 17.7%
Analyst target
$34.42 +36.5%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$23.75 -5.8%
E2$22.59 -10.4%
E3$20.02 -20.6%
Targets
T1$26.51 5.1%
T2$27.58 9.4%
T3$28.75 14.0%
Stop-loss
SL$19.32 -23.4%
Whale cost ~$22.59 -10.4%

Risk : reward 1 : 1.9Moves ~$0.70 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
  • ●แข็งแกร่งกว่าตลาด (S&P 500) +30% ใน 6 เดือน
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 34.42 (upside +36%, 12 ราย)
! Risks (1)
  • ●เซียนขายออก/ลดสัดส่วน 1 ราย: Joel Greenblatt (ลด)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Swartz Allison · Officer

2026-09-23 · 3,903 shares @ $26.10 · pre-planned sale (10b5-1)

$101,868
Sell

GORDON KEVIN K · Director

2026-09-10 · 11,500 shares @ $27.94

$321,358
Sell

GORDON KEVIN K · Director

2026-09-10 · 11,500 shares @ $27.12

$311,858
Sell

Cummings Melissa B · COO

2026-07-14 · 2,244 shares @ $31.60 · pre-planned sale (10b5-1)

$70,910
Sell

Livingston Mark S. · CFO

2026-06-04 · 1,918 shares @ $25.50 · pre-planned sale (10b5-1)

$48,909
Sell

Livingston Mark S. · CFO

2026-06-04 · 599 shares @ $25.50 · pre-planned sale (10b5-1)

$15,275
Sell

Swartz Allison · Officer

2026-06-04 · 599 shares @ $25.08 · pre-planned sale (10b5-1)

$15,023
Sell

Swartz Allison · Officer

2026-06-03 · 1,199 shares @ $25.02 · pre-planned sale (10b5-1)

$29,999
Sell

Clapp Geoffrey · Officer

2026-06-02 · 1,530 shares @ $25.58

$39,137
Sell

Livingston Mark S. · CFO

2026-06-02 · 279 shares @ $26.20 · pre-planned sale (10b5-1)

$7,310
Sell

Scott Cheryl · Director

2026-06-01 · 7,439 shares @ $26.39

$196,278
Sell

Swartz Allison · Officer

2026-05-28 · 2,398 shares @ $25.46 · pre-planned sale (10b5-1)

$61,053
Sell

GORDON KEVIN K · Director

2026-05-27 · 5,500 shares @ $24.99

$137,445
Sell

Livingston Mark S. · CFO

2026-05-20 · 8,275 shares @ $25.50 · pre-planned sale (10b5-1)

$211,013
Sell

Cummings Melissa B · COO

2026-05-19 · 9,578 shares @ $25.00 · pre-planned sale (10b5-1)

$239,450

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$2.0B
Next earnings2026-11-05
P/E (price to earnings)27.7
Forward P/E (on expected earnings)11.0
Revenue growth (YoY)+5.3%
Earnings growth (YoY)+78.9%
Net profit margin+6.0%
ROE+16.2%
Debt to equity (D/E)6%
Dividend yield-
Analyst targets (high / low)$40.00 / $30.00
Number of analysts12
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Uptrend ↗
RSI38
MA50 / MA200$27.48 / $24.22
Distance from MA200+4.1%
MACDNegative
1-year high / low$33.06 / $16.10
vs. S&P 500 (6 months)+29.8%
Volume vs. average0.13×